Moderna, Merck shares soar on success of mRNA cancer vaccine
Moderna and Merck’s mRNA cancer vaccine showed positive results in a late-stage melanoma trial.The vaccine could be available as soon as next year if regulators approve it.
Moderna shares surged as much as 160% following the results.
Moderna developed the vaccine with Merck and tested it together with Keytruda, a common immunotherapy treatment for melanoma.
This is the first successful late-stage trial for an mRNA cancer vaccine. The vaccine works by training a patient’s immune system to recognize and attack specific mutations in cancer cells. It is also the first study to show that adding another treatment to Keytruda worked better than Keytruda alone. Similar vaccines are being studied for lung, breast and pancreatic cancers.
LiveNOW’s Mike Pache spoke about the medical breakthrough, and how the market responded to the news, with Barron’s Mackenzie Tatananni.
Subscribe to LiveNOW from FOX! https://www.youtube.com/livenowfox?sub_confirmation=1
Where to watch LiveNOW from FOX: https://www.livenowfox.com
Follow us @LiveNOWFOX on TikTok: https://www.tiktok.com/@livenowfox
Raw and unfiltered. Watch a non-stop stream of breaking news, live events and stories across the nation. Limited commentary. No opinion. Experience LiveNOW from FOX. Live news streaming channel when and where you need it. Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to Moderna, Merck shares soar on success of mRNA cancer vaccine
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
